This site uses cookies.
Some of these cookies are essential to the operation of the site,
while others help to improve your experience by providing insights into how the site is being used.
For more information, please see the ProZ.com privacy policy.
VIA AILooking for an interpreter?
Remoto by ProZ.com connects you with an identity-verified interpreter by video or phone in about 60 seconds — 300+ languages, on demand or booked ahead.
Try Remoto »
Member since Oct '26
Working languages:
English to Portuguese Portuguese (monolingual) Portuguese to English English (monolingual)
Client-vendor relationship recorded successfully!
Flavio Matsubara has been added to your list of hired vendors.
This person is not affiliated with any business or Blue Board record at ProZ.com.
Services
Translation, Editing/proofreading, Subtitling, AI + Human review (MT post-editing), Transcription, Linguistic validation
Expertise
Specializes in:
Medical: Health Care
Medical (general)
Medical: Pharmaceuticals
Medical: Oncology
Medical: Cardiology
Safety Data Sheets/Regulations
Medical: Dentistry
Medical: Instruments
Rates
General rate: 0.1 USD per word / 40 USD per hour
Portfolio
Sample translations submitted: 1
English to Portuguese: Package Insert Leaflet (PIL) for CALQUENCE® (acalabrutinib) (sample text) General field: Medical Detailed field: Medical: Pharmaceuticals
Source text - English CALQUENCE® (acalabrutinib) tablets, for oral use
Initial U.S. Approval: 2017
INDICATIONS AND USAGE
CALQUENCE is a kinase inhibitor indicated:
• In combination with bendamustine and rituximab for the treatment of adult patients with previously untreated mantle cell lymphoma (MCL) who are ineligible for autologous hematopoietic stem cell transplantation (HSCT).
• For the treatment of adult patients with MCL who have received at least one prior therapy.
• For the treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
Translation - Portuguese CALQUENCE® (acalabrutinibe) comprimidos, para uso oral
Aprovação inicial nos EUA: 2017
INDICAÇÕES E USO
CALQUENCE é um inibidor de quinase indicado:
• Em combinação com bendamustina e rituximabe para o tratamento de pacientes adultos com linfoma de células do manto (LCM) não tratado previamente, que não sejam elegíveis para transplante autólogo de células-tronco hematopoiéticas (TCTH).
• Para o tratamento de pacientes adultos com LCM que receberam pelo menos uma terapia anterior.
• Para o tratamento de pacientes adultos com leucemia linfocítica crônica (LLC) ou linfoma linfocítico de pequenas células (LLPC).
More
Less
Translation education
Bachelor's degree - Universidade Estadual de Maringá (UEM)
Experience
Years of experience: 14. Registered at ProZ.com: Sep 2026. Became a member: Oct 2026.
Get help on technical issues / improve my technical skills
Learn more about the business side of freelancing
Stay up to date on what is happening in the language industry
Buy or learn new work-related software
Improve my productivity
Bio
Experienced medical translator/proofreader/post-editor/transcripter specializing in Life Sciences (clinical research, pharmaceutical, and healthcare) content, with 14+ years translating protocols, ICFs, IBs, package inserts, IRB/IEC submissions and scientific publications. Brings strong regulatory knowledge (FDA, EMA, ICH-GCP), QA discipline, and proven on-time delivery across 100+ clinical trial projects on several therapeutic areas. Focus on accuracy, consistency, and patient-facing clarity in EN/PT medical translation and post-editing workflows.
Member since Oct '26
Portfolio 
CV/Resume (DOCX)